EGFR and non-small cell lung carcinoma: In this systematic review and network meta-analysis, we comprehensively summarized the comparative efficacy and safety of multiple first-line combination strategies based on third generation EGFR-TKIs in patients with advanced EGFR mutated NSCLC.